Bentysrepinine
Bentysrepinine (Y101) is an orally active HBV inhibitor with anti-hepatitis B virus infection activity. Bentysrepinine exhibits favorable pharmacokinetic characteristics, with absolute bioavailability of 44.9%, 43.1%, and 19.2% in rats, dogs, and monkeys, respectively, and it does not accumulate in monkeys after 90 days of oral administration. Bentysrepinine is under research in the antiviral and hepatitis fields[1][2].
Product Specifications
CAS Number
934264-38-7
Product Name Alternative
Y101
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bentysrepinine.html
Smiles
CN(C)CCOC(C=C1)=CC=C1C[C@H](NC(C2=CC=CC=C2)=O)C(N[C@H](CO)CC3=CC=CC=C3)=O
Molecular Formula
C29H35N3O4
Molecular Weight
489.61
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MAML2 (Mastermind-like Protein 2, Mam-2, MAML2, KIAA1819) (MaxLight 750) discontinued
Tut1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)